Rapt Therapeutics, Inc.股价重挫34.21% 市值跌6250.1万美元

自选股智能写手05-09

北京时间2024年05月09日21时30分，Rapt Therapeutics, Inc.（RAPT.us）股票出现波动，股价快速下挫34.21%。截至发稿，该股报5.25美元/股，成交量45.0446万股，换手率1.29%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.17亿美元，每股收益-3.05美元，毛利-3.55百万美元，市盈率-1.72倍。机构评级方面，在...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2434018083?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-05-09 21:30","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2434018083","market":"us","top_or_hot":-1,"title":"Rapt Therapeutics, Inc.股价重挫34.21% 市值跌6250.1万美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年05月09日21时30分，Rapt Therapeutics, Inc.（RAPT.us）股票出现波动，股价快速下挫34.21%。截至发稿，该股报5.25美元/股，成交量45.0446万股，换手率1.29%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.17亿美元，每股收益-3.05美元，毛利-3.55百万美元，市盈率-1.72倍。机构评级方面，在...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509213004861ec173&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rapt Therapeutics, Inc.股价重挫34.21% 市值跌6250.1万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRapt Therapeutics, Inc.股价重挫34.21% 市值跌6250.1万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-05-09 21:30 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509213004861ec173&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年05月09日21时30分，Rapt Therapeutics, Inc.（RAPT.us）股票出现波动，股价快速下挫34.21%。截至发稿，该股报5.25美元/股，成交量45.0446万股，换手率1.29%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.17亿美元，每股收益-3.05美元，毛利-3.55百万美元，市盈率-1.72倍。机构评级方面，在...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509213004861ec173&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509213004861ec173&s=b","article_id":"2434018083","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509213004861ec173&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2434018083","pubTimestamp":1715261403,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年05月09日21时30分，Rapt Therapeutics, Inc.股票出现波动，股价快速下挫34.21%。截至发稿，该股报5.25美元/股，成交量45.0446万股，换手率1.29%，振幅0.00%。Rapt Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。其相关个股中，Cel-Sci Corporation、Cyclerion Therapeutics, Inc.、Assembly Biosciences, Inc.涨幅较大，Allarity Therapeutics, Inc.、Cytomx Therapeutics, Inc.、Alzamend Neuro, Inc.较为活跃，换手率分别为34.02%、9.47%、3.74%，振幅较大的相关个股有Actinium Pharmaceuticals, Inc. 、Immunitybio, Inc.、Cel-Sci Corporation，振幅分别为0.34%、0.13%、0.01%。Rapt Therapeutics, Inc.公司简介：RAPT Therapeutics Inc 是一家基于临床阶段的免疫学生物制药公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LENZ":"Therapeutics","RAPT":"RAPT Therapeutics, Inc.","BK4139":"生物科技"},"translate_title":"Rapt Therapeutics, Inc. 's stock price plummeted 34.21%, and its market value fell by $62.501 million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"RAPT":0.9},"content_text":"北京时间2024年05月09日21时30分，Rapt Therapeutics, Inc.（RAPT.us）股票出现波动，股价快速下挫34.21%。截至发稿，该股报5.25美元/股，成交量45.0446万股，换手率1.29%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.17亿美元，每股收益-3.05美元，毛利-3.55百万美元，市盈率-1.72倍。机构评级方面，在所有12家参与评级的机构中，58%的券商给予买入建议，42%的券商给予持有建议，无券商给予卖出建议。Rapt Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。其相关个股中，Cel-Sci Corporation、Cyclerion Therapeutics, Inc.、Assembly Biosciences, Inc.涨幅较大，Allarity Therapeutics, Inc.、Cytomx Therapeutics, Inc.、Alzamend Neuro, Inc.较为活跃，换手率分别为34.02%、9.47%、3.74%，振幅较大的相关个股有Actinium Pharmaceuticals, Inc. (Delaware)、Immunitybio, Inc.、Cel-Sci Corporation，振幅分别为0.34%、0.13%、0.01%。Rapt Therapeutics, Inc.公司简介：RAPT Therapeutics Inc 是一家基于临床阶段的免疫学生物制药公司。它专注于发现、开发和商业化口服小分子疗法用于未满足需求的肿瘤和炎症疾病患者。该公司的管道产品包括FLX475，旨在选择性地抑制免疫抑制调节性T细胞向肿瘤的迁移;RPT193，旨在选择性地抑制2型T辅助细胞向炎症组织的迁移。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2434018083"}